Analysis of budgetary impact of moderate and high risk non muscle-invasive bladder cancer by means of neoadjuvant hyperthermia chemotherapy compared to the standard adjuvant treatment with BCG

1. Sousa, A.
2. Piñeiro, I.
3. Aparici, V.
4. Neira, P.
5. Monserrat, V.
6. Uribarri, C.